

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Mollie Matteson mmatteson@biologicaldiversity.org
The U.S. Fish and Wildlife Service today protected the red knot as a threatened species under the Endangered Species Act. The robin-sized shorebird, which twice a year makes an epic 9,000-mile migration between southern South America and the Canadian Arctic, has declined by 75 percent since the 1980s. Threatened by loss of an essential food, horseshoe crabs, as well as habitat destruction, the bird is also at risk from climate change, which threatens to destroy many of its shoreline stopover areas as well as its breeding habitat in the far north. Today's decision was made in accordance with a settlement requirement with the Center for Biological Diversity that requires the agency to make decisions on protection for 757 species.
"With today's decision to protect the red knot, our children and grandchildren just may have the chance to marvel at one of nature's greatest spectacles -- the marathon migration of the red knot," said Mollie Matteson, a senior scientist with the Center. "Saving the red knot will certainly require stricter restrictions on harvest of horseshoe crabs for both bait and the medical industry, highlighting how connected the world we live in is."
Red knots fly 9,300 miles from the southern tip of South America to the Arctic, making a major stop along the North American mid-Atlantic coast to regain their strength by feeding on calorie-rich horseshoe crab eggs. However, since the 1990s, the eel and conch-fishing industries, which use the crab for bait, and the biomedical industry, which uses the crab's unique, copper-rich blood to test drugs and medical devices for bacterial contamination, have caused severe declines in horseshoe crabs -- themselves unique animals that have been on the planet for hundreds of millions of years.
Fisheries managers in mid-Atlantic states have begun to address the overharvest of horseshoe crabs with new regulations, but it is unclear if those rules go far enough, and it may be years before crab populations recover. The biomedical industry releases most horseshoe crabs after extracting some of their blood, but many crabs die after handling and losing as much as a third of their blood.
The extensive mudflats and beaches of Delaware Bay are the most significant stopover for migrating red knots. Scientists have estimated that nearly 90 percent of the entire red knot population can be present on the Delaware Bay in a single day.
Delaware Riverkeeper Network and other groups sent a petition to the Fish and Wildlife Service for emergency listing of the red knot in 2005. A year later the Service determined the birds warranted protection, but did not provide that protection due to lack of resources. Under the Center's settlement, the agency proposed the knot for protection in 2013 and is now finalizing that protection. To date 141 species have been protected under the agreement, including the red knot.
At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature — to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law and creative media, with a focus on protecting the lands, waters and climate that species need to survive.
(520) 623-5252"Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations."
A report released Tuesday by Democrats on the Senate Finance Committee details how US President Donald Trump and Republicans in Congress are waging a multifront war on children by targeting healthcare programs, education, and nutrition assistance as part of their scorched-earth assault on the nation's safety net and redistribution of wealth to the very top.
"In just months, the Trump administration has gutted access to healthcare for millions of children, slashed funding for school meals and nutrition assistance, fired thousands of workers dedicated to advancing child welfare and protecting children, and unleashed policies that traumatize and harm immigrant families and LGBTQ+ youth," reads the report. "These actions are not isolated—they reflect a coordinated agenda that will leave a generation of children sicker, hungrier, and less safe."
As part of the sprawling budget reconciliation package that Trump signed into law over the summer, Republicans enacted the largest-ever cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP), slashing more than $1 trillion combined from the two programs.
Roughly half of all kids in the US are covered by either Medicaid or the Children's Health Insurance Program, and around 40% of SNAP beneficiaries are children, meaning cuts to those programs will have far-reaching impacts on the nation's youth in the coming years.
"By making the largest cuts to healthcare and food assistance in the nation’s history, Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations," Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee, said in a statement on Tuesday.
"By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
In addition to denouncing cuts to Medicaid and SNAP, the new report outlines how the Trump administration is imperiling mental health programs by canceling grants and other funding, harming children's education by throttling Head Start funds, and inflicting deadly cuts to programs that aid kids overseas—all while delivering massive tax cuts to the richest Americans and largest corporations.
"Trump’s cuts to healthcare access, food assistance, and education have stripped millions of kids of the care, nutrition, and protection they need to thrive," the report states. "By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
"Unless stopped," the report concludes, "Trump’s war on kids will leave lasting scars on millions of children and weaken the nation for decades to come."
"He’s not thinking about the democratization of Venezuela, let alone the narco-trafficking," said the Latin American leader. "In general, all of the wars of this century had to do with oil."
Colombian President Gustavo Petro said Tuesday that US President Donald Trump's central focus with his attacks and threats against Venezuela is the desire for the nation's vast oil reserves and little if anything to do with stopping illegal drug trafficking or improving the nation's democratic prospects under President Nicolas Maduro.
In an face-to-face interview with CNN's Isa Soeres, which the correspondent described as "fiery" at times, Petro explained that Venezuela's oil reserves, among the largest in the world, is "at the heart of the matter" when it comes to Trump's repeated extrajudicial killings in waters of the nation's coast this year and a broader military buildup that includes deployment of the USS Gerald R. Ford aircraft carrier group and mobilization of US Southern Command.
"What lies behind this," said Petro, "is the same thing behind the war in Ukraine... petroleum," noting the size and quality of Venezuela's reserves. "In general, all of the wars of this century had to do with oil."
If Trump were to get the upper hand, Petro suggested, the United States would get Venezuela's oil "almost for free," predicting that—"based on the evidence so far"—that the US will go to war over the resources.
Trump, said Petro, "is not thinking about the democratization of Venezuela, let alone the narco-trafficking," adding that Venezuela is not considered a major drug producer or transit point for most narcotics headed to the United States.
"You only have to look at the numbers," said Petro. "Only about 4 percent of Colombia's cocaine production... goes through Venezuela—a small margin—while most of it goes out through the Pacific Ocean."
As CNN notes, "Petro has been at odds with Trump since he returned to the White House. In the past year, the Colombian leader has harshly criticized the Trump administration’s immigration policies, its support for Israel and its military activity around Latin America."
In September, the US State Department under Trump had Petro's visa revoked following critical comments he made during the UN General Assembly in New York.
This week, the US designated a new group, the Cartel do Los Soles, as a terrorist organization, naming Maduro its de facto leader, a claim that experts say there is no evidence to support.
Asked by CNN if he assesses Maduro as a gang leader, dictator, or narcotrafficker, Petro said investigations in Colombia have never shown Maduro to be connected to the black market drug trade and that his country's data doesn't even show the existence of the alleged cartel designated this week by the Trump administration.
"The problem of Maduro," said Petro, "is lack of democracy and dialogue."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," said one Democratic senator.
The Trump administration on Tuesday announced newly negotiated prices for more than a dozen prescription drugs covered by Medicare, an achievement made possible by a Biden-era law that has faced relentless attacks from the pharmaceutical industry, GOP lawmakers, and the Republican president.
The announcement marks the end of the second round of Medicare drug price negotiations required under the Inflation Reduction Act (IRA), a measure passed in 2022 without the support of a single Republican in Congress. Last year, House GOP leaders said the law was "disastrous" and decried what they called "the mandate from bureaucrats to artificially set prescription drug prices."
The new list contains 15 drugs, including the diabetes and weight loss medication Ozempic, the breast cancer drug Ibrance, and the prostate cancer drug Xtandi. The Centers for Medicare & Medicaid Services (CMS) estimated that if the new prices—which take effect in 2027—had been in effect last year, Medicare would have saved $12 billion.
President Donald Trump campaigned on rolling back the IRA, which for the first time allowed Medicare to negotiate drug prices directly with pharmaceutical companies. Since taking office, Trump has taken steps to weaken the law, including by signing a measure that will exempt certain high-priced drugs from Medicare negotiations—a multibillion-dollar handout to Big Pharma.
But in statements on Tuesday, Trump-appointed officials hailed the newly negotiated prices. Robert F. Kennedy Jr., secretary of the Health and Human Services Department, said the negotiation results stemmed from a Trump directive to "stop at nothing to lower healthcare costs for the American people."
CMS Administrator Mehmet Oz declared that the second round of negotiations was more successful than the first, which was held under the Biden administration. Experts said that claim is specious at best.
Democratic lawmakers were quick to highlight Republican opposition to the IRA, and continued attacks on the law, in response to the newly negotiated prices.
"Democrats took on Big Pharma by giving Medicare the power to negotiate on behalf of the tens of millions of seniors that want lower drug prices while every Republican voted against it,” said Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee. “Today’s announcement is a result of that effort by Democrats to lower health costs for older Americans."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," Wyden added. "Republicans neutered future Medicare drug price negotiations by adding delays and exemptions to some of the most expensive drugs, especially cancer drugs like Keytruda."
Tuesday's announcement came less than a week after the pharmaceutical industry suffered its 16th defeat in court as it continues its legal campaign against the Medicare price negotiations. The industry is also lobbying aggressively in support of legislation that would further weaken the IRA price-negotiation provisions.
"Drug corporations already secured a $9 billion giveaway from President Trump and congressional Republicans paid for by taxpayers and cancer patients through the Big Ugly Bill, and they are trying to go even further to delay and exempt price negotiations for more blockbuster drugs," said Steve Knievel, access to medicines advocate at Public Citizen.
"Policymakers must reject these efforts to undermine Medicare drug price negotiations," Knievel added. "Instead they should build on the program’s success by providing everyone access to negotiated prices, negotiating lower prices for more drugs sooner, and ensuring drug corporations can no longer rip us off by charging the highest prices in the world for medications."